A new prospective trial finds AI assistance significantly increases detection of suspicious lung nodules in low-dose chest CT screenings.
Key Details
- 1Published in American Journal of Roentgenology; study compares radiologist performance with and without AI support.
- 2First prospective real-world evidence addressing limitations of prior retrospective research on AI in lung cancer screening.
- 3Study involved consecutive asymptomatic patients undergoing low-dose chest CT from May to September 2025.
- 4Patients were randomized to AI-assisted interpretation or radiologist-only reading arms.
- 5Primary outcomes measured: interpretation times and nodule detection rates, with secondary analysis on follow-up recommendations.
Why It Matters
Prospective, real-world data are essential for validating AI performance beyond retrospective analyses. The results support integrating AI into routine lung cancer screening, potentially improving early lung cancer detection and workflow efficiency.
Source
Radiology Business
Related News
•AuntMinnie
GPT-4o AI Matches Radiologists in Follow-Up Imaging Recommendations
GPT-4o matched the performance of experienced radiologists and surpassed residents in recommending follow-up imaging from routine radiology reports.
•Cardiovascular Business
AI Leverages Head CTs for Automated Heart Risk Assessments
AI models can turn routine head CT scans into automated cardiovascular risk assessments, expanding the utility of radiology studies.
•Radiology Business
GE HealthCare’s True Definition DL Receives FDA Clearance for CT Imaging
GE HealthCare's True Definition DL, a deep learning-based CT image reconstruction tool, has received FDA 510(k) clearance.